| Amee K Dharia, MD | |
|
825 Main St, Weymouth, MA 02190-1659 | |
| (781) 337-3424 | |
| (781) 340-3782 |
| Full Name | Amee K Dharia |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 28 Years |
| Location | 825 Main St, Weymouth, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376575498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 209191 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Shore Hospital | South weymouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts Eye And Ear Associates, Inc | 4486540275 | 337 |
News Archive
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
Using 10-year-old archival brain tissue from patients with Alzheimer's disease, a research team from NYU Langone Medical Center has developed a novel method to examine the structure and function of proteins at the cell level-providing greater means to study protein changes found in Alzheimer's disease.
In a world-first, decompression surgery has been shown to be an effective procedure to treat cervical spondylotic myelopathy - a common progressive, degenerative disease of the spine that can lead to paralysis - according to the results of a multi-centre clinical trial published today.
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 5 days ago
| Entity Name | Massachusetts Eye And Ear Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123 |
News Archive
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
Using 10-year-old archival brain tissue from patients with Alzheimer's disease, a research team from NYU Langone Medical Center has developed a novel method to examine the structure and function of proteins at the cell level-providing greater means to study protein changes found in Alzheimer's disease.
In a world-first, decompression surgery has been shown to be an effective procedure to treat cervical spondylotic myelopathy - a common progressive, degenerative disease of the spine that can lead to paralysis - according to the results of a multi-centre clinical trial published today.
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amee K Dharia, MD 825 Main St, Weymouth, MA 02190-1659 Ph: (781) 337-3424 | Amee K Dharia, MD 825 Main St, Weymouth, MA 02190-1659 Ph: (781) 337-3424 |
News Archive
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
Using 10-year-old archival brain tissue from patients with Alzheimer's disease, a research team from NYU Langone Medical Center has developed a novel method to examine the structure and function of proteins at the cell level-providing greater means to study protein changes found in Alzheimer's disease.
In a world-first, decompression surgery has been shown to be an effective procedure to treat cervical spondylotic myelopathy - a common progressive, degenerative disease of the spine that can lead to paralysis - according to the results of a multi-centre clinical trial published today.
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 5 days ago
Dr. Cathy D Chong, M.D., M.P.H. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-337-3424 Fax: 781-337-7569 | |
Hani Ibrahim, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-337-3424 Fax: 781-337-7569 | |
Robin Brittany Pappal, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-337-3424 | |
Richard S Hill, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-803-6380 Fax: 781-803-6379 | |
Bridget Driscoll Burgess, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St Fl 1, Weymouth, MA 02190 Phone: 781-337-3424 |